Global private equity and venture capital news and research

Posts Tagged ‘Roche Venture Fund’

24 July 2015

Abingworth leads $22m Series A in vaccine company SutroVax

injection_lrg London-based venture capital Abingworth has led a $22m Series A financing round in biopharmaceutical vaccine company SutroVax.

24 November 2014

QIAGEN, LSP join extended €14.5m Series B financing in Curetis

euro Molecular diagnostic solutions company Curetis has announced the extension of its Series B financing with new investors QIAGEN and LSP Health Economics Fund committing a total of €7m.

2 October 2014

Venture capital-backed Alios BioPharma sold to Johnson & Johnson for $1.75bn

sale-1306463-m Clinical stage biopharmaceutical company Alios BioPharma has been bought by multinational healthcare business Johnson & Johnson for around $1.75bn in cash.

9 April 2014

Mystery investor joins venture backers in $41m Alios BioPharma Series B

virus2_sq A string of venture capital firms have renewed their backing of biotech business Alios BioPharma to help it develop treatments for respiratory viral diseases.

18 November 2013

Imperial Innovations heads up £20m investment in biotech developer Mission Therapeutics

UK technology commercialisation and investment firm Imperial Innovations has committed £4.5m of a £20m funding round for biotechnology company Mission Therapeutics alongside corporate venture investor Pfizer Venture Investments and existing investors Sofinnova Partners, SR One and Roche Venture Fund.

17 October 2013

Biodesy raises $15m Series A from 5AM Ventures, Pfizer, Roche

biotech_lrg Biotech business Biodesy has raised a $15m Series A round from venture capital firms 5AM Ventures, Pfizer Venture Investments and Roche Venture Fund.

29 April 2013

Venture firms queue up to back €33m Opsona Series C round

Opsona BB Biotech Ventures and Novartis Venture Fund have led a €33m Series C financing round for autoimmune system and inflammatory disease drug developer Opsona.

17 December 2012

Novo Ventures leads $32m financing for biotech company Allakos

virus2_sq Denmark-based Novo Ventures has led a $32m Series A preferred stock financing round for antibody-focused biotechnology company Allakos.

20 September 2012

Cancer diagnostics company Foundation Medicine adds $42.5m

Foundation Medicine has completed a $42.5m Series B financing with participation from public crossover funds, strategic investors and existing venture capital backers.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016